{
    "nctId": "NCT01614041",
    "officialTitle": "Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder: a Multi-center, Randomized, Usual Dose-controlled Trial",
    "inclusionCriteria": "* 18-65 years old\n* Male or female\n* Diagnosed with GAD according to DSM-IV\n* HAMA score\u226517\n* Provide with written informed consent\n* Agree to be washed-out for two weeks if receiving SSRI, SNRI or NASA.\n* Must have minimum age of 18 Years\n* Must have maximum age of 65 Years",
    "exclusionCriteria": "* Serious suicidal tendency\n* The score of the sixth item of HAMA \u22653\n* The score of HAMD \u226521\n* Pregnant or lactating women\n* History of allergic or hypersensitivity to tandospirone\n* Serious or unstable cardiac, renal, neurologic, cerebrovascular, metabolic, or pulmonary disease\n* Secondary anxiety disorders\n* Drug or alcohol dependence within 1 year\n* Patients currently taking benzodiazepine drugs\n* Drivers and dangerous machine operators\n* Participated in other clinical studies in the last 30 days\n* Patients with clinically significant ECG or laboratory abnormalities\n* Patients with a history of epilepsy\n* Patients with abnormal TSH concentration"
}